Stopping infectious diseases is among the urgent health challenges that must be advocated for in the next decade, as declared by the World Health Organization (WHO)¹. There are many long-term goals to work towards so that we may improve these world health challenges. As a whole, it’s a complicated ordeal, but there are also actionable starting points where Sysmex can provide insight when it comes to infectious diseases, as several studies have shown. These include:

Early identification or exclusion of infectious diseases
Differentiation of underlying pathogens
Quick disease monitoring
Reliable therapy decision support
Aid in antimicrobial stewardship

In close collaboration with international research networks as well as our customers, we are striving for the continuous increase of knowledge on infectious diseases. Health care professionals must make difficult therapy decisions every day based on the latest clinical evidence. We feel a responsibility to support them with new knowledge for confident therapy decision making in fighting infectious diseases.

Explore Sysmex’s solutions.

^{1 WHO: Urgent health challenges}

COVID-19

COVID-19: How can routine diagnostic parameters support in clinical decision making?

Full blood count, haemostasis parameters and urinalysis can provide guidance in

- Identification of patients of high risk for SARS-CoV-2 infection
- Patient risk stratification
- Prognostic markers for patient survival

Get more out of your routine lab parameters

Malaria

Experts all over the world have the same questions when they face a patient suspected with a malaria infection.

Does my patient have malaria or not?
Can I expect a severe or an uncomplicated malaria?
How can I monitor the treatment success?

Find out more about malaria and new possibilities for diagnosis